Similar articles for PMID: 26149698

Year	Number of Results
1954	1
1961	1
1980	1
1992	1
1998	1
1999	1
2000	1
2001	1
2004	2
2005	8
2006	4
2007	4
2008	5
2009	9
2010	5
2011	5
2012	6
2013	5
2014	6
2015	8
2016	11
2017	9
2018	8
2019	4
2020	2
2021	2
2022	1

1

Strongyloidiasis in immigrants and refugees in Canada.

Thompson C, Boggild AK. Thompson C, et al. CMAJ. 2015 Dec 8;187(18):1389. doi: 10.1503/cmaj.141441. Epub 2015 Jul 6. CMAJ. 2015. PMID: 26149698 Free PMC article. No abstract available.

2

Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?

Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S. Biggs BA, et al. Am J Trop Med Hyg. 2009 May;80(5):788-91. Am J Trop Med Hyg. 2009. PMID: 19407125

3

Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.

Salluh JI, Feres GA, Velasco E, Holanda GS, Toscano L, Soares M. Salluh JI, et al. Intensive Care Med. 2005 Sep;31(9):1292. doi: 10.1007/s00134-005-2725-y. Epub 2005 Jul 22. Intensive Care Med. 2005. PMID: 16041520 No abstract available.

4

Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis.

Bitterman A, Martins CP, Cices A, Nadendla MP. Bitterman A, et al. JAMA Netw Open. 2022 Mar 1;5(3):e223079. doi: 10.1001/jamanetworkopen.2022.3079. JAMA Netw Open. 2022. PMID: 35311963 Free PMC article.

5

Constipation and weight loss in a Honduran immigrant.

Ajumobi A, Magulick J, Wright R. Ajumobi A, et al. Gastroenterology. 2015 Jun;148(7):e3-4. doi: 10.1053/j.gastro.2014.11.005. Epub 2015 Apr 30. Gastroenterology. 2015. PMID: 25935529 No abstract available.

6

Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.

Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR. Marty FM, et al. Clin Infect Dis. 2005 Jul 1;41(1):e5-8. doi: 10.1086/430827. Epub 2005 May 11. Clin Infect Dis. 2005. PMID: 15937753

7

[Clinical and epidemiological characteristics of strongyloidiasis in patients with comorbidities].

Regueira Fernandes A, Romero S, Alcântara de Souza Melo PF, Ramos Araújo PS, Bottasso O, Rocha A, Brandão E. Regueira Fernandes A, et al. Rev Chilena Infectol. 2017 Feb;34(1):47-53. doi: 10.4067/S0716-10182017000100007. Rev Chilena Infectol. 2017. PMID: 28394981 Free article. Review. Spanish.

8

Management of severe strongyloidiasis attended at reference centers in Spain.

Martinez-Perez A, Roure Díez S, Belhassen-Garcia M, Torrús-Tendero D, Perez-Arellano JL, Cabezas T, Soler C, Díaz-Menéndez M, Navarro M, Treviño B, Salvador F; Soil-Transmitted Helminths’ Study Group of the Spanish Society of Tropical Medicine and International Health (SEMTSI). Martinez-Perez A, et al. PLoS Negl Trop Dis. 2018 Feb 23;12(2):e0006272. doi: 10.1371/journal.pntd.0006272. eCollection 2018 Feb. PLoS Negl Trop Dis. 2018. PMID: 29474356 Free PMC article.

9

Human strongyloidiasis: often brushed under the carpet.

Mirdha BR. Mirdha BR. Trop Gastroenterol. 2009 Jan-Mar;30(1):1-4. Trop Gastroenterol. 2009. PMID: 19624080 No abstract available.

10

[Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].

Manrique-Rodríguez S, Martín-Rabadán P, Díaz-Cámara M, Fernández-Llamazares CM. Manrique-Rodríguez S, et al. Med Clin (Barc). 2016 Apr 15;146(8):376-7. doi: 10.1016/j.medcli.2015.10.008. Epub 2015 Dec 2. Med Clin (Barc). 2016. PMID: 26654554 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed